scholarly journals Parents’ Behaviors and Experiences Associated with Four Vaccination Behavior Groups for Childhood Vaccine Hesitancy

2022 ◽  
Author(s):  
Morgan E. Ellithorpe ◽  
Robyn Adams ◽  
Fashina Aladé
Keyword(s):  
Vaccine Hesitancy ◽  
Vaccination Behavior ◽  
Childhood Vaccine

scholarly journals What Determines Vaccine Hesitancy: Recommendations from Childhood Vaccine Hesitancy to Address COVID-19 Vaccine Hesitancy

Vaccines ◽  
2022 ◽  
Vol 10 (1) ◽  
pp. 80
Author(s):  
Farren Rodrigues ◽  
Suzanne Block ◽  
Suruchi Sood
Keyword(s):  
Literature Review ◽  
Conceptual Model ◽  
Vaccine Uptake ◽  
Childhood Vaccination ◽  
Vaccine Hesitancy ◽  
Extensive Literature ◽  
Health Providers ◽  
Multifaceted Approach ◽  
What Works ◽  
Childhood Vaccine

Vaccine hesitancy is a prevalent and ongoing issue. However, due to the COVID-19 pandemic, additional attention has been brought to the topic of vaccine hesitancy. Vaccine hesitancy is a threat to the population’s health globally. This article aims to acquire insights from previous literature to determine what works to increase vaccine uptake and how we can apply this knowledge to increase COVID-19 vaccine uptake. Research has focused chiefly on childhood vaccination and the hesitancy of caregivers. After conducting an extensive literature review, we have created a conceptual model of indicators that influence vaccine uptake for health providers and caregivers, which can also be used for vaccine recipients. Overall, the reasons for vaccine hesitancy are complex; therefore, a multifaceted approach is needed to address it. Understanding the factors that affect vaccine hesitancy will aid in addressing hesitancy and, in turn, lead to an increase in vaccine uptake.

A meta-synthesis study of the key elements involved in childhood vaccine hesitancy

Public Health ◽  
2020 ◽  
Vol 180 ◽  
pp. 38-45 ◽  
Author(s):  
M.E. Díaz Crescitelli ◽  
L. Ghirotto ◽  
H. Sisson ◽  
L. Sarli ◽  
G. Artioli ◽  
...  
Keyword(s):  
Vaccine Hesitancy ◽  
Childhood Vaccine

scholarly journals How are sociodemographic factors and risk preferences associated with seasonal influenza vaccination behavior under the COVID-19 pandemic?

2021 ◽  
Author(s):  
TAKAHIRO MORI ◽  
Tomohisa Nagata ◽  
Kazunori Ikegami ◽  
Ayako Hino ◽  
Seiichiro Tateishi ◽  
...  
Keyword(s):  
Influenza Vaccination ◽  
Seasonal Influenza ◽  
Risk Preference ◽  
Sociodemographic Factors ◽  
Internet Survey ◽  
Vaccine Hesitancy ◽  
Seasonal Influenza Vaccination ◽  
Vaccination Rates ◽  
Vaccination Behavior ◽  
The Relationship

Background: Vaccine hesitancy is an issue for vaccines required for herd immunity. Although various factors such as sociodemographics can affect vaccine hesitancy, the research results differ and it is unclear whether these differences depend on the subjects or the situation, such as the type of infection or vaccine. Therefore, we investigated the relationship between seasonal influenza vaccination behavior and sociodemographic factors under the COVID-19 pandemic. In addition, we analyzed the relationship between individual factors of risk preference and seasonal influenza vaccination on the premise that there is a difference in the association between efficacy and the risk of side effects of the two vaccines. Methods: A cross-sectional study was conducted on workers aged from 20-65 years on December 22-25, 2020, using data from an Internet survey. We set the presence or absence of 2020/2021 seasonal influenza vaccination as the dependent variable, and each aspect of sociodemographic factors and risk preference as independent variables. We performed a multilevel logistic regression analysis nested by residence. Results: In total, 26,637 respondents (13,600 men, 13,037 women) participated. Significantly more women than men were vaccinated. Both men and women had higher vaccination rates if married, highly educated, with high income, and with underlying disease. Men aged 60-65 had a significantly higher vaccination rate than those aged 20-29, while women aged 40-49 and 50-59 had a significantly lower rate than those aged 20-29. These results differed from those of a previous study on the vaccination intentions of the same subjects for COVID-19. Those with low risk preference had higher vaccination rates than those with high risk preference. Conclusions: Our results suggested that the effect of sociodemographic factors on vaccine hesitancy depends on the situation affecting efficacy of the vaccine and the perception of vaccination risk.

scholarly journals Online misinformation and vaccine hesitancy

2021 ◽  
Author(s):  
Renee Garett ◽  
Sean D Young
Keyword(s):  
Social Media ◽  
Vaccine Hesitancy ◽  
Effective Vaccine ◽  
Vaccine Preventable Disease ◽  
Misleading Information ◽  
Preventable Disease ◽  
Media Companies ◽  
Online Social Media ◽  
Childhood Vaccine ◽  
Health Experts

Lay Summary Vaccine hesitancy, the rejection or delay to get vaccinated even if there is an effective vaccine available, may be instrumental in the resurgence of vaccine-preventable disease. Studies have shown that the rise in nonmedical exemptions for vaccination increases rates of childhood vaccine-preventable disease. One factor that influences vaccine hesitancy is online misinformation. False or misleading information online regarding vaccines can be found in independent news outlets, websites, and social media. The spread of vaccine misinformation is especially important during the COVID-19 pandemic as false information can decrease pro-vaccine opinions. The recent announcement of an effective COVID-19 vaccine became a hot topic online, with many adults hesitant to take the vaccine. Public health experts, medical professionals, and pro-vaccine individuals can help curb the spread of misinformation by correcting false statements online. Social media companies can also aid in stopping misinformation by implementing and enforcing policy that limits misinformation on their platforms.

scholarly journals Understanding Drivers of Vaccine Hesitancy among Pregnant Women in Nigeria: A Longitudinal Study

2021 ◽  
Author(s):  
Gbadebo Adeyanju ◽  
Cornelia Betsch ◽  
Philipp Sprengholz
Keyword(s):  
Longitudinal Study ◽  
Pregnant Women ◽  
Collective Responsibility ◽  
Healthcare Facility ◽  
Stress Constraints ◽  
Sampling Procedure ◽  
Sub Saharan Africa ◽  
Childhood Vaccination ◽  
Vaccine Hesitancy ◽  
Vaccination Behavior

Abstract Background: Vaccine-preventable diseases are major contributors to the disease burden in Sub-Saharan Africa, accounting for many childhood illnesses, disabilities, and mortality. There is dearth of knowledge on the drivers of vaccine hesitancy in Nigeria and the extent of its impact on coverage. Pregnant women are a particularly important vulnerable and at-risk group and, additionally, very relevant for childhood vaccination decisions. However, this group is understudied in Nigeria. This study’s aims are to adapt Confidence, Complacency, Constraints, Calculation, and Collective Responsibility, also known as the 5C psychological antecedence scale for the Nigerian context and to measure vaccine hesitancy to predict the intention to vaccinate among pregnant women (prenatal) and subsequent vaccination behavior (postnatal). Method: It is a longitudinal study that used multi-stage sampling procedure. One healthcare facility was selected from each district in five regional clusters, from which 255 pregnant women were randomly drawn. A standardized questionnaire was used to collect data on demographic characteristics, sources of vaccination information, and the 5C psychological antecedents of vaccination. Additional variables tested included the importance of religion, masculinity, and rumor/conspiracy theory. The scale’s reliability was explored, and a backward elimination regression analysis was performed to identify the major determinants of childhood vaccination intention among pregnant women (T1) and their postnatal behavior (T2). Results: The prenatal (T1) findings revealed low reliability of the 5C subscales in Nigeria’s setting. Pregnant women’s intention to vaccinate unborn children was lower if they were Muslims, had lower confidence in public authorities or the health system, if husband approval was important for vaccination, and if they believed in rumor. Postnatal (T2) findings revealed that vaccination was more likely to follow mothers’ religious beliefs, when confidence in vaccine effectiveness was high and when mothers felt responsible for the collective. However, higher levels of everyday stress (constraints) were related to less vaccination behavior, and intention did not predict actual vaccination behavior. Conclusion: The 5C scale is incompletely adaptable in Nigeria but is a better tool for measuring vaccination behavior than intention. Overall, the vaccination intention did not predict behavior among pregnant women. The additional variables are good instruments that need further exploration.

scholarly journals Influenza Vaccine Hesitancy in Patients with Multiple Sclerosis: A Monocentric Observational Study

2021 ◽  
Vol 11 (7) ◽  
pp. 890
Author(s):  
Antonio Ziello ◽  
Cristina Scavone ◽  
Maria Elena Di Battista ◽  
Simona Salvatore ◽  
Daniele Di Giulio Cesare ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Observational Study ◽  
Vaccination Campaign ◽  
Healthcare Providers ◽  
Dimethyl Fumarate ◽  
Vaccine Hesitancy ◽  
Flu Vaccination ◽  
Vaccination Behavior ◽  
Almost All ◽  
Vaccination Campaigns

Background. The so-called “vaccine hesitancy” still represents a common phenomenon that undermines the effectiveness of vaccination campaigns. In 2020, the Italian Medicines Agency recommended to bring forward the flu vaccination campaign, whose importance was also emphasized for patients with Multiple Sclerosis (MS). We aimed to assess vaccination behavior in patients with MS to prepare for the upcoming SARS-CoV-2 vaccination challenge. Methods. This is an observational study carried out in one MS clinical Centre that enrolled all MS patients who were eligible for any of the flu vaccines recommended by the Italian medicines Agency. Results. 194 patients were enrolled. Patients’ mean age was 43.9 years and 66% were female. Comorbidities, mainly represented by non-autoimmune diseases, were identified in 52% of patients. Almost all patients were receiving a DMT during the study period, mainly dimethyl fumarate, natalizumab, teriflunomide, and interferon. Out of 194 patients, 58.2% accepted to be vaccinated. No statistically significant differences were found, except for the use of natalizumab, which was higher among vaccinated patients. Conclusion. The results of our study emphasize the importance of education and communication campaigns addressed both to healthcare providers and patients with MS, especially considering that MS patients are currently receiving COVID-19 vaccinations.

scholarly journals Vaccine confidence and hesitancy in Brazil

2018 ◽  
Vol 34 (9) ◽  
Author(s):  
Amy Louise Brown ◽  
Marcelo Sperandio ◽  
Cecília P. Turssi ◽  
Rodrigo M. A. Leite ◽  
Victor Ferro Berton ◽  
...  
Keyword(s):  
Emergency Services ◽  
Health Workers ◽  
Vaccine Hesitancy ◽  
Family Planning Services ◽  
Clear Trend ◽  
Vaccine Preventable Diseases ◽  
Face To Face ◽  
Vaccination Behavior ◽  
Vaccine Confidence ◽  
Status Level

Despite the overall benefits of immunization, vaccine hesitancy has been a growing trend and has been associated with the resurgence of vaccine-preventable diseases. The aim of this study was to assess vaccine confidence and hesitancy in Brazil, as part of a wider project to map vaccine confidence globally. One thousand subjects were interviewed, either online or face-to-face, based on a general questionnaire regarding perceptions on vaccines and vaccination. Further exploratory questions were used with the subset of respondents who were parents of children aged under 5. Such questions extracted information regarding vaccination behavior, opinions on vaccination and government health services, and vaccine hesitancy. Reasons for hesitancy were classified as relating to confidence, convenience and/or complacency, and the population was also analyzed socio-demographically. The results showed that overall confidence in immunization was higher than confidence in family planning services, community health workers and emergency services. Seventy-six people reported hesitancy to vaccinate. The commonest reasons for hesitancy were issues with confidence (41.4%), efficacy/safety of the vaccine (25.5%) and concerns about adverse events (23.6%). The sociodemographic analysis revealed that vaccine hesitancy was associated with marital status, level of education and income. Despite overall vaccine confidence being high, a clear trend toward lower levels of confidence was associated with higher levels of hesitancy, which warrants on-going monitoring, due to the dynamic and changing nature of vaccine hesitancy.

Sharp rise in vaccine hesitancy in a large and representative sample of the French population: reasons for vaccine hesitancy.

2020 ◽  
Author(s):  
Anne-Sophie Hacquin ◽  
Sacha Altay ◽  
Emma de Araujo ◽  
Coralie Chevallier ◽  
Hugo Mercier
Keyword(s):  
At Risk ◽  
Educational Level ◽  
Representative Sample ◽  
Vaccine Hesitancy ◽  
The Political ◽  
French Population ◽  
Sharp Rise ◽  
Vaccine Refusal ◽  
French People ◽  
Nationally Representative

A safe and effective COVID-19 vaccine is our only hope to decisively stop the spread of the SARS-CoV-2. But a vaccine will only be fully effective if a significant share of the population agrees to get it. Five consecutive surveys of a large, nationally representative sample (N = 1000 for each wave) surveyed attitudes towards a future COVID-19 vaccine in France from May 2020 to October 2020. We found that COVID-19 vaccine refusal has steadily increased, reaching an all-time high with only 23% of participants willing to probably or certainly take a future COVID-19 vaccine in September 2020. Vaccine hesitant individuals are more likely to be women, young, less educated, to vote at the political extremes, to be dissatisfied with the government’s response to the COVID-19 crisis, and to feel less at risk of COVID-19. The reasons why French people would refuse to take the COVID-19 vaccine are similar to those offered for other vaccines, and these reasons are strikingly stable across gender, age and educational level. Finally, most French people declare they would not take the vaccine as soon as possible but would instead rather wait or not take it at all.

Sign in / Sign up

Export Citation Format

Share Document